Handelsbanken Fonder Ab Avidity Biosciences, Inc. Call Options Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RNA
# of Institutions
258Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$327 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$279 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$255 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$240 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$235 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.54B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...